| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/09/1999 | US5869539 Source of nitric oxide; administering to treat hypertension, or where increased blood flow is desirable; no negative side effects due to drug metabolites |
| 02/09/1999 | US5869538 Method for enhancing transport of gases to tissues |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869530 Dietetic phospholipid compositions and use thereof as a dietary supplement |
| 02/09/1999 | US5869462 Inhibition of proliferation of vascular smooth muscle cell |
| 02/09/1999 | US5869306 Gene transfer preparation |
| 02/09/1999 | US5869248 Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| 02/09/1999 | US5869170 Preparation of medical devices by solid free-form fabrication methods |
| 02/09/1999 | US5869117 Immobilizing viable yeast cells in polymer beads for use in a malt beverage fermentation process |
| 02/09/1999 | US5869103 Blend of a biodegradable polymer and water soluble polymer improves loading and gives a linear release profile of biologically active agents such as peptides, dna and proteins |
| 02/09/1999 | US5869102 Solid pharmaceutical compositions containing (S)-2-(4-isobutylphenyl) propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 02/09/1999 | US5869101 Process for the preparation of S(+)-ibuprofen-particles |
| 02/09/1999 | US5869100 Tablet comprising clonidine, cellulose ether, adjunct selected from corn starch, lactulose, dextrose |
| 02/09/1999 | US5869098 Includes at least one flowable, partially crystallized amorphous matrix comprising carbohydrate(s) and sugar alcohol(s) and a tableting aid with a bio-affecting agent |
| 02/09/1999 | US5869097 Method of therapy comprising an osmotic caplet |
| 02/09/1999 | US5869096 Oral osmotic device with hydrogel driving member |
| 02/09/1999 | US5869095 Chewable tablet with an effervescent action |
| 02/09/1999 | US5869094 Solid form of administration of isosorbide 5-mononitrate |
| 02/09/1999 | US5869092 Prevention of leakage and phase separation during thermotropic phase transition in liposomes and biological cells |
| 02/09/1999 | US5869091 Aqueous vehicle, vesicle comprising nonionic surfactant, sterol and charged species suspended in aqueous vehicle and pharmaceutically active agent in both vesicle and aqueous vehicle |
| 02/09/1999 | US5869089 Manufacturing method of programmable transdermal therapeutic system |
| 02/09/1999 | US5869088 Preparation containing fatty acid, fatty acid ester or alcohol as absorption enhancer |
| 02/09/1999 | US5869087 Patch having a preparation for external use attached thereto |
| 02/09/1999 | US5869086 Systems for the controlled release of pilocarpine |
| 02/09/1999 | US5869082 Buccal, non-polar spray for nitroglycerin |
| 02/09/1999 | US5869081 Progesterone vaginal ring for treatment of infertility |
| 02/09/1999 | US5869079 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 02/09/1999 | US5869078 Fluid from body is used to provide a force which delivers a treatment agent |
| 02/09/1999 | US5869077 Subcutaneously implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete insulin dispersed in biocompatible matrix, surrounded by biocompatible external permselective jacket |
| 02/09/1999 | US5869072 Skin moisturization, without preservatives or undesirable greasy or oily residue |
| 02/09/1999 | US5869034 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution |
| 02/09/1999 | US5868846 Vacuum nozzle assembly |
| 02/09/1999 | US5868142 Implantable device |
| 02/09/1999 | CA2226091C Cyclosporin-containing soft capsule preparations |
| 02/09/1999 | CA2151385C Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis |
| 02/04/1999 | WO1999005303A1 Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method |
| 02/04/1999 | WO1999005183A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 02/04/1999 | WO1999004824A1 Polymer based pharmaceutical compositions for targeted delivery of biologically active agents |
| 02/04/1999 | WO1999004823A1 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles |
| 02/04/1999 | WO1999004821A2 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/04/1999 | WO1999004819A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/04/1999 | WO1999004799A1 Fatty emulsions containing reducing sugar and method for sterilizing the same |
| 02/04/1999 | WO1999004798A1 Lyophilized fosphenytoin sodium for parenteral use |
| 02/04/1999 | WO1999004790A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative |
| 02/04/1999 | WO1999004788A1 Aqueous compositions comprising ranitidine and lcmt sucrose |
| 02/04/1999 | WO1999004787A1 Taxol emulsion |
| 02/04/1999 | WO1999004773A2 Method for inhibiting bone resorption |
| 02/04/1999 | WO1999004768A2 Osmotic delivery system flow modulator apparatus |
| 02/04/1999 | WO1999004767A2 Osmotic delivery system with semipermeable plug |
| 02/04/1999 | WO1999004766A1 Method for preparing vesicular nanocapsules |
| 02/04/1999 | WO1999004765A2 Pharmaceutical compositions containing an effervescent acid-base couple |
| 02/04/1999 | WO1999004764A1 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity |
| 02/04/1999 | WO1999004763A1 Improved multiparticulate tablet with quick disintegration |
| 02/04/1999 | WO1999004762A2 Entrapping additives in carbohydrate bodies |
| 02/04/1999 | WO1999004761A1 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein |
| 02/04/1999 | WO1999004760A1 Spherical single-substance particles, medicines and foodstuffs containing the particles, and method of production thereof |
| 02/04/1999 | WO1999004759A1 Homeopathic granules and method for making same |
| 02/04/1999 | WO1999004758A1 A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
| 02/04/1999 | WO1998050016A3 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 02/04/1999 | WO1998048821A3 Use of conantokins for producing analgesia or for neuroprotection |
| 02/04/1999 | DE19811402A1 Preparation of medicaments for treatment of tumours |
| 02/04/1999 | DE19734544A1 Schellackhaltiges kosmetisches Produkt Shellac-containing cosmetic product |
| 02/04/1999 | DE19733505A1 Schnell wirksames Analgeticum Fast-acting analgesic |
| 02/04/1999 | DE19733094A1 Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität Formulation based on ascorbic acid with improved color stability |
| 02/04/1999 | DE19732903A1 Pellet-Formulierung zur Behandlung des Intestinaltraktes The pellet formulation for the treatment of the intestinal tract |
| 02/04/1999 | CA2301166A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/04/1999 | CA2298930A1 Pharmaceuticals for modulating hormone responsiveness |
| 02/04/1999 | CA2298065A1 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/04/1999 | CA2297760A1 Method for preparing vesicular nanocapsules |
| 02/04/1999 | CA2297487A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 02/04/1999 | CA2297418A1 Entrapping additives in carbohydrate bodies |
| 02/04/1999 | CA2297025A1 Polymer based pharmaceutical compositions for targeted delivery of biologically active agents |
| 02/04/1999 | CA2296654A1 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity |
| 02/04/1999 | CA2296562A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative |
| 02/04/1999 | CA2295037A1 Aqueous compositions comprising ranitidine and lcmt sucrose |
| 02/04/1999 | CA2212300A1 In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| 02/03/1999 | EP0894807A1 GPIb-LIPID COMPLEX AND USES THEREOF |
| 02/03/1999 | EP0894495A1 Bioadhesive embossed tablets |
| 02/03/1999 | EP0894139A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 02/03/1999 | EP0894129A1 Short external guide sequences |
| 02/03/1999 | EP0894127A2 Methods for increasing the maturation of cells |
| 02/03/1999 | EP0894043A1 Method of forming articles and patterning surfaces via capillary micromolding |
| 02/03/1999 | EP0894010A2 Denaturants for sympathomimetic amine salts |
| 02/03/1999 | EP0894009A1 Improved vision through photodynamic therapy of the eye |
| 02/03/1999 | EP0893999A1 Process for producing efonidipine hydrochloride preparations |
| 02/03/1999 | EP0893998A1 Colonic delivery of nicotine to treat inflammatory bowel disease |
| 02/03/1999 | EP0893994A2 Diclofenac/gamma-cyclodextrin inclusion compounds |
| 02/03/1999 | EP0893992A2 Fast disintegrating oral dosage form |
| 02/03/1999 | EP0893990A1 Ophthalmological composition of the type which undergoes liquid-gel phase transition |
| 02/03/1999 | EP0893989A1 Compounds combining allopathic substances with corresponding homeopathic substances |
| 02/03/1999 | EP0777414B1 Sprayable film forming system releasing active substances for use on plants |
| 02/03/1999 | EP0729352B1 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
| 02/03/1999 | EP0652747B1 Controlled release morphine preparation |
| 02/03/1999 | EP0576425B1 Method for inactivating sperm |
| 02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
| 02/03/1999 | CN2305997Y Sealed double-sticking adhesive plaster |
| 02/03/1999 | CN1207076A Improved storage wrap material |
| 02/03/1999 | CN1207049A Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-'beta'-estradiol to the human organism |
| 02/03/1999 | CN1207044A Cyclosporin-containing soft capsule preparations |
| 02/03/1999 | CN1207036A Granulates for cosmetic and pharmaceutical preparations |